Rubric Capital Management LP is required to file a 13D/G report to the SEC when the ownership of a company's total stock issue exceeds 5%.
Filed | Shares | Percentage | |
---|---|---|---|
HERON THERAPEUTICS, INC. /DE/ | July 25, 2023 | 26,713,503 | 19.0% |
Amryt Pharma plc | February 10, 2023 | 18,000,000 | 5.6% |
BGC Partners, Inc. | February 10, 2023 | 18,250,000 | 5.6% |
EverQuote, Inc. | February 10, 2023 | 1,246,622 | 4.8% |
Ferroglobe PLC | February 10, 2023 | 3,232,762 | 1.7% |
Sio Gene Therapies Inc. | February 10, 2023 | 7,000,000 | 9.5% |
Vincerx Pharma, Inc. | February 10, 2023 | 386,719 | 1.8% |
Whole Earth Brands, Inc. | February 10, 2023 | 998,363 | 2.4% |
Radius Health, Inc. | June 16, 2022 | 6,959,305 | 14.6% |
ANTARES PHARMA, INC. | February 14, 2022 | 10,800,000 | 6.4% |
Core Scientific, Inc./txSold out | February 14, 2022 | 0 | 0.0% |
MAGNACHIP SEMICONDUCTOR Corp | February 14, 2022 | 872,308 | 1.9% |
CHIASMA, INC | June 07, 2021 | 7,250,000 | 12.5% |
Green Plains Inc. | February 16, 2021 | 1,056,330 | 3.0% |
NET 1 UEPS TECHNOLOGIES INC | February 16, 2021 | 2,132,622 | 3.8% |
STEMLINE THERAPEUTICS INC | February 14, 2020 | 3,500,000 | 7.0% |